Bioxytran, Inc. announced the preprint in ResearchGate entitled ?Association of Rapid Shingles Lesion Clearance and Regression of Herpes Zoster Neuralgia in Case Study Using Topical Galectin-3 Antagonism? showed a time lapsed clearance of the shingles lesions using a topical Galectin-3 antagonist. Vaccines have been developed to prevent shingles, but there are few effective antiviral therapies capable of treating the outbreak while reducing the pain associated with the condition.

The case study demonstrated a rapid response in the reduction of pain the size of the lesion area, due to a galectin antagonist.